Payment overview · 2025
General Payments
$44.72
2 reported records · 2 companies
Healthcare provider profile · identity verified
Aaron Trone, M.D.
Allopathic & Osteopathic Physicians|General Practice · VANDALIA, MO · NPI 1265403869
Verified facts
What the public records show
CMS Open Payments records show Aaron Trone, M.D. received $44.72 in general payments during 2025 across 2 reported records.
Tactile Systems Technology Inc accounted for 75.4% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 4 associated products.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Tactile Systems Technology Inc | Unresolved — no canonical attribution shown | $33.70 | 75.4% | 1 | 2025 |
| Kerecis Limited | Unresolved — no canonical attribution shown | $11.02 | 24.6% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $44.72 | 2 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| Flexitouch Plus Normalized: flexitouch plus |
Device | Tactile Systems Technology Inc | $33.70 | 1 | 2025 |
Source payment records
|
|||||
| Nimbl Normalized: nimbl |
Device | Tactile Systems Technology Inc | $33.70 | 1 | 2025 |
Source payment records
|
|||||
| Kerecis GraftGuide Normalized: kerecis graftguide |
Device | Kerecis Limited | $11.02 | 1 | 2025 |
Source payment records
|
|||||
| Kerecis SurgiClose Normalized: kerecis surgiclose |
Device | Kerecis Limited | $11.02 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
None of this doctor’s payer companies has same-entity product evidence that passes the publication threshold. The site does not infer company ownership, affiliates, or generic manufacturers.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 326 | 63 |
| Gabapentin | Gabapentin | 307 | 51 |
| Levothyroxine Sodium | Levothyroxine Sodium | 293 | 47 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 221 | 39 |
| Lisinopril | Lisinopril | 220 | 46 |
| Amlodipine Besylate | Amlodipine Besylate | 218 | 37 |
| Losartan Potassium | Losartan Potassium | 206 | 39 |
| Omeprazole | Omeprazole | 194 | 36 |
| Pantoprazole Sodium | Pantoprazole Sodium | 188 | 38 |
| Potassium Chloride | Potassium Chloride | 183 | 35 |
| Trazodone Hcl | Trazodone Hcl | 172 | 26 |
| Tamsulosin Hcl | Tamsulosin Hcl | 158 | 31 |
| Hydrochlorothiazide | Hydrochlorothiazide | 151 | 29 |
| Furosemide | Furosemide | 147 | 26 |
| Tizanidine Hcl | Tizanidine Hcl | 143 | 24 |
| Sertraline Hcl | Sertraline Hcl | 141 | 25 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 130 | 29 |
| Metoprolol Tartrate | Metoprolol Tartrate | 126 | 18 |
| Meloxicam | Meloxicam | 121 | 26 |
| Tramadol Hcl | Tramadol Hcl | 116 | 25 |
| Escitalopram Oxalate | Escitalopram Oxalate | 114 | 13 |
| Alprazolam | Alprazolam | 112 | 19 |
| Metoprolol Succinate | Metoprolol Succinate | 111 | 25 |
| Carvedilol | Carvedilol | 109 | 18 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 108 | 14 |
| Fluticasone Propionate | Fluticasone Propionate | 107 | 29 |
| Pregabalin | Pregabalin | 100 | 18 |
| Metformin Hcl | Metformin Hcl | 89 | 12 |
| Warfarin Sodium | Warfarin Sodium | 89 | suppressed |
| Clopidogrel | Clopidogrel Bisulfate | 87 | 14 |
| Donepezil Hcl | Donepezil Hcl | 86 | suppressed |
| Eliquis | Apixaban | 86 | 14 |
| Fluoxetine Hcl | Fluoxetine Hcl | 85 | suppressed |
| Ozempic | Semaglutide | 83 | 17 |
| Celecoxib | Celecoxib | 81 | 13 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 79 | 13 |
| Metformin Hcl Er | Metformin Hcl | 76 | 16 |
| Allopurinol | Allopurinol | 72 | 16 |
| Valsartan | Valsartan | 72 | 14 |
| Oxycodone Hcl | Oxycodone Hcl | 68 | suppressed |
| Pravastatin Sodium | Pravastatin Sodium | 68 | 11 |
| Desvenlafaxine Succinate Er | Desvenlafaxine Succinate | 66 | 11 |
| Simvastatin | Simvastatin | 66 | 12 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 65 | 11 |
| Spironolactone | Spironolactone | 60 | 14 |
| Doxazosin Mesylate | Doxazosin Mesylate | 56 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 55 | suppressed |
| Jardiance | Empagliflozin | 53 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 52 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 52 | suppressed |
| Zolpidem Tartrate | Zolpidem Tartrate | 52 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 49 | 32 |
| Quetiapine Fumarate | Quetiapine Fumarate | 48 | suppressed |
| Montelukast Sodium | Montelukast Sodium | 44 | 11 |
| Buspirone Hcl | Buspirone Hcl | 43 | suppressed |
| Diazepam | Diazepam | 43 | suppressed |
| Famotidine | Famotidine | 43 | 14 |
| Oxybutynin Chloride | Oxybutynin Chloride | 42 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 41 | suppressed |
| Methocarbamol | Methocarbamol | 41 | suppressed |
| Lorazepam | Lorazepam | 40 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 39 | 14 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 38 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 38 | suppressed |
| Duloxetine Hcl | Duloxetine Hcl | 37 | 11 |
| Torsemide | Torsemide | 37 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 35 | suppressed |
| Atenolol | Atenolol | 33 | suppressed |
| Temazepam | Temazepam | 33 | suppressed |
| Mounjaro | Tirzepatide | 31 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 31 | suppressed |
| Topiramate | Topiramate | 31 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 30 | suppressed |
| Ibuprofen | Ibuprofen | 30 | 11 |
| Fenofibrate | Fenofibrate Nanocrystallized | 28 | suppressed |
| Finasteride | Finasteride | 28 | suppressed |
| Bupropion Xl | Bupropion Hcl | 27 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 27 | suppressed |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 27 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 26 | suppressed |
| Dexlansoprazole Dr | Dexlansoprazole | 26 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 26 | 16 |
| Citalopram Hbr | Citalopram Hydrobromide | 25 | suppressed |
| Glimepiride | Glimepiride | 25 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 25 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 25 | suppressed |
| Diltiazem 12hr Er | Diltiazem Hcl | 24 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 24 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 23 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 23 | suppressed |
| Trulicity | Dulaglutide | 23 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 22 | suppressed |
| Clonazepam | Clonazepam | 22 | suppressed |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 22 | suppressed |
| Fenofibrate | Fenofibrate | 22 | suppressed |
| Labetalol Hcl | Labetalol Hcl | 22 | suppressed |
| Levemir Flexpen | Insulin Detemir | 22 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 22 | suppressed |
| Morphine Sulfate Er | Morphine Sulfate | 22 | suppressed |
| Prednisone | Prednisone | 22 | suppressed |
| Januvia | Sitagliptin Phosphate | 21 | suppressed |
| Myrbetriq | Mirabegron | 21 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 21 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 20 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 20 | suppressed |
| Novolog Flexpen | Insulin Aspart | 20 | suppressed |
| Synthroid | Levothyroxine Sodium | 20 | suppressed |
| Butalbital-Acetaminophen-Caffe | Butalb/Acetaminophen/Caffeine | 19 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 19 | suppressed |
| Linzess | Linaclotide | 19 | suppressed |
| Loperamide | Loperamide Hcl | 19 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 18 | 15 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 18 | 13 |
| Incruse Ellipta | Umeclidinium Bromide | 18 | suppressed |
| Lovastatin | Lovastatin | 18 | suppressed |
| Fluconazole | Fluconazole | 17 | 11 |
| Norethin-Eth Estra-Ferrous Fum | Noreth-Ethinyl Estradiol/Iron | 17 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 17 | suppressed |
| Autoshield Duo Pen Needle | Pen Needle,dual Safety,diabetc | 16 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 16 | suppressed |
| Memantine Hcl | Memantine Hcl | 16 | suppressed |
| Nystatin | Nystatin | 16 | suppressed |
| Rabeprazole Sodium | Rabeprazole Sodium | 16 | suppressed |
| Baclofen | Baclofen | 15 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 15 | suppressed |
| Febuxostat | Febuxostat | 15 | suppressed |
| Memantine Hcl Er | Memantine Hcl | 15 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 14 | suppressed |
| Naproxen | Naproxen | 14 | suppressed |
| Prazosin Hcl | Prazosin Hcl | 14 | suppressed |
| Testosterone Cypionate | Testosterone Cypionate | 14 | suppressed |
| Amoxicillin | Amoxicillin | 13 | suppressed |
| Cyanocobalamin Injection | Cyanocobalamin (Vitamin B-12) | 13 | suppressed |
| Dayvigo | Lemborexant | 13 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 13 | suppressed |
| Latanoprost | Latanoprost | 13 | suppressed |
| Risperidone | Risperidone | 13 | suppressed |
| Azithromycin | Azithromycin | 12 | suppressed |
| Bisoprolol Fumarate | Bisoprolol Fumarate | 12 | suppressed |
| Brilinta | Ticagrelor | 12 | suppressed |
| Colesevelam Hcl | Colesevelam Hcl | 12 | suppressed |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 12 | suppressed |
| Diphenoxylate-Atropine | Diphenoxylate Hcl/Atropine | 12 | suppressed |
| Erythromycin | Erythromycin Base | 12 | suppressed |
| Ezetimibe | Ezetimibe | 12 | suppressed |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 12 | suppressed |
| Levofloxacin | Levofloxacin | 12 | suppressed |
| Movantik | Naloxegol Oxalate | 12 | suppressed |
| Nadolol | Nadolol | 12 | suppressed |
| Nystop | Nystatin | 12 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 12 | suppressed |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 12 | suppressed |
| Advair Diskus | Fluticasone Propion/Salmeterol | 11 | suppressed |
| Arexvy | Rsvpref3 Antigen/As01e/Pf | 11 | 11 |
| Cephalexin | Cephalexin | 11 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 11 | suppressed |
| Isosorbide Dinit-Hydralazine | Isosorbide Dinit/Hydralazine | 11 | suppressed |
| Mometasone Furoate | Mometasone Furoate | 11 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 11 | suppressed |
| Sevelamer Carbonate | Sevelamer Carbonate | 11 | suppressed |
| Spiriva Respimat | Tiotropium Bromide | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $44.72 · 2 records | Tactile Systems Technology Inc | Flexitouch Plus, Kerecis GraftGuide, Kerecis SurgiClose, Nimbl | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error